Embryo applies high‑throughput embryonic development, genomic analysis, and AI‑driven design to create novel, genetically engineered organisms such as a horned horse “unicorn.” Its services target biotech research, sustainable agriculture, xenomedicine, and custom companion‑animal development, generating revenue through licensing of engineered traits, custom organism contracts, and downstream therapeutic or agricultural applications.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional methods of genetically modifying animals are often inefficient, imprecise, and lack real-time feedback on embryonic development and genetic expression. This makes it difficult to predictably engineer specific traits or ensure the viability of modified embryos.
Solution
Los Angeles Project (LAP) is developing a biotechnology platform that combines genomic analysis, precision gene editing, automated embryonic development, and computer vision to engineer novel life forms. The platform identifies genes responsible for specific traits, precisely edits embryonic DNA to express those traits, and uses AI-powered computer vision to track genetic expression and embryo viability in real-time. This allows for the creation of animals with specifically designed genetic traits, such as disease resistance, improved health, or unique physical characteristics.
Target Audience
LAP's primary customers include researchers and organizations focused on medical innovation, species conservation, and sustainable agriculture, as well as individuals interested in owning genetically modified animals.
Features
- Genomic analysis to identify genes responsible for specific traits (e.g., horn growth).
- Precision gene editing to modify embryonic DNA.
- Automated, high-throughput embryonic development.
- AI-powered computer vision for real-time tracking of genetic expression and embryo viability.
- Scalable embryo editing platform.